Table 2.
Sample characteristics at Phase 1 of those participants included into the analysis.
| Phase 1 | ||||
|---|---|---|---|---|
| “Increasing” trajectory (N = 43) | “Resilient” trajectory (N = 430) | Provisional PTSD (N = 36) | No PTSD (N = 437) | |
| Age | 27.16 (5.99) | 25.66 (5.92) | 26.67 (6.15) | 25.73 (5.92) |
| Gender (% females) | 11.6% (N = 5) | 5.3% (N = 23) | 13.9% (N = 5) | 5.3% (N = 23) |
| PCL-5 score | 14.12 (16.66) | 2.63 (5.37) | 13.83 (17.17) | 2.84 (5.83) |
| PHQ-8 score | 4.5 (5.13) | 1.31 (2.49) | 4.54 (5.33) | 1.36 (2.55) |
| GAD-7 score | 5.55 (5.42) | 1.65 (2.64) | 5.4 (5.57) | 1.72 (2.75) |
| AUDIT score | 2.43 (3.28) | 2.23 (2.50) | 2.58 (3.57) | 2.22 (2.48) |
| PSQI score | 8.46 (3.79) | 4.88 (2.9) | 8 (3.63) | 4.97 (3.01) |
| DRRI-2 score | 51.7 (22.5) | 35.94 (16.5) | 50.86 (23.73) | 36.52 (16.86) |
| TBI status: improbable | 63.4% (N = 26) | 84.6% (N = 356) | 61.8% (N = 21) | 84.3% (N = 361) |
| TBI status: possible | 12.1% (N = 5) | 5.7% (N = 24) | 14.7% (N = 5) | 5.6% (N = 24) |
| TBI status: mild | 14.6% (N = 6) | 8.1% (N = 34) | 11.8% (N = 4) | 8.4% (N = 36) |
| TBI status: moderate | 9.8% (N = 4) | 1% (N = 4) | 11.8% (N = 4) | 0.9% (N = 4) |
| TBI status: severe | 0% (N = 0) | 0.7% (N = 3) | 0% (N = 0) | 0.7% (N = 3) |
| CSI current | 15.44 (12.22) | 5.73 (8.92) | 16.15 (12.82) | 6.01 (9.02) |
| CSI lifetime | 27.94 (18.72) | 12.35 (15.2) | 25.69 (15.21) | 13.45 (16.7) |
| Number of previous deployments | 1.09 (1.54) | 0.76 (1.11) | 0.81 (1.31) | 0.79 (1.15) |
PCL-5 PTSD Checklist for DSM-5, PHQ-8 Patient Health Questionnaire, GAD-7 Generalized Anxiety Disorder; AUDIT Alcohol Use Identification Test, PSQI Pittsburgh Sleep Quality Index, DRRI-2 Deployment Risk and Resilience Inventory-2, TBI traumatic brain injury, CSI Concussion Symptoms Inventory (current (past month) and lifetime (month in which symptoms were their “worst”)).